ARTICLES

somryst pear therapeutics insomnia
Insomnia

Somryst for Chronic Insomnia Via a Virtual Care Experience

Pear Therapeutics, Inc., announced the availability of Somryst™, the first prescription digital therapeutic (PDT) intended for use in the treatment of patients 22 years of age and older with chronic insomnia. Somryst addresses the underlying issues of chronic insomnia by delivering cognitive behavioral therapy for insomnia (CBTi), an evidence-based approach […]

liberate medical
Research & Studies

VentFree Respiratory Muscle Stimulator Shows Positive Results

Applying non-invasive electrical stimulation to the expiratory abdominal muscles may reduce abdominal muscle atrophy and markedly reduce the number of days adult patients require mechanical ventilation – a potentially important finding for weaning ventilated patients, including seriously ill COVID-19 patients and improving patient outcomes. Liberate Medical has announced the results […]

lung melatonin Prevents Coronavirus
Research & Studies

Antidepressant May Prevent Severe COVID-19

The antidepressant fluvoxamine appears to prevent COVID-19 infections from worsening and may help keep patients out of the hospital, a trial based on research from the University of Virginia School of Medicine suggests. The clinical trial, conducted by the Washington University School of Medicine in St. Louis, compared fluvoxamine with […]